Roth MKM lowered the firm’s price target on Tilray to $1.75 from $2 and keeps a Neutral rating on the shares. The company’s Q1 results were “light” on revenue and adjusted EBITDA following its “strong beat” in Q4, with EBITDA coming in at the lowest level since Q1 of 2021, the analyst tells investors in a research note. The quarter underscores the core, organic pressure that Tilray business has faced while its organic growth remains elusive, the firm added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLRY:
- Tilray Earnings Report: Did it Beat Expectations?
- Tilray price target lowered to $1.75 from $2.25 at Alliance Global Partners
- Delta reports mixed Q3, Domino’s reports earnings beat: Morning Buzz
- Rising High: Exclusive talk with cannabis REIT NewLake Capital
- TLRY Earnings: Tilray Brands Plummets as Q1 Revenues Fall Short of Estimates